295 related articles for article (PubMed ID: 28152507)
21. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas.
Yan Q; Huang Y; Watkins AJ; Kocialkowski S; Zeng N; Hamoudi RA; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
Haematologica; 2012 Apr; 97(4):595-8. PubMed ID: 22102703
[TBL] [Abstract][Full Text] [Related]
22. A specific mutation in TBL1XR1 causes Pierpont syndrome.
Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
[TBL] [Abstract][Full Text] [Related]
23. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin.
Vela V; Juskevicius D; Dirnhofer S; Menter T; Tzankov A
Virchows Arch; 2022 Feb; 480(2):403-413. PubMed ID: 34494161
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma.
Kim WS; Honma K; Karnan S; Tagawa H; Kim YD; Oh YL; Seto M; Ko YH
Genes Chromosomes Cancer; 2007 Aug; 46(8):776-83. PubMed ID: 17492759
[TBL] [Abstract][Full Text] [Related]
25. Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas.
Zhu D; Ikpatt OF; Dubovy SR; Lossos C; Natkunam Y; Chapman-Fredricks JR; Fan YS; Lossos IS
Am J Hematol; 2013 Sep; 88(9):730-5. PubMed ID: 23720088
[TBL] [Abstract][Full Text] [Related]
26. The genetic landscape of dural marginal zone lymphomas.
Ganapathi KA; Jobanputra V; Iwamoto F; Jain P; Chen J; Cascione L; Nahum O; Levy B; Xie Y; Khattar P; Hoehn D; Bertoni F; Murty VV; Pittaluga S; Jaffe ES; Alobeid B; Mansukhani MM; Bhagat G
Oncotarget; 2016 Jul; 7(28):43052-43061. PubMed ID: 27248180
[TBL] [Abstract][Full Text] [Related]
27. A20 inactivation in ocular adnexal MALT lymphoma.
Bi Y; Zeng N; Chanudet E; Huang Y; Hamoudi RA; Liu H; Dong G; Watkins AJ; Ley SC; Zou L; Chen R; Zhu X; Du MQ
Haematologica; 2012 Jun; 97(6):926-30. PubMed ID: 22207688
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
[TBL] [Abstract][Full Text] [Related]
29. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
[TBL] [Abstract][Full Text] [Related]
30. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.
Venturutti L; Teater M; Zhai A; Chadburn A; Babiker L; Kim D; Béguelin W; Lee TC; Kim Y; Chin CR; Yewdell WT; Raught B; Phillip JM; Jiang Y; Staudt LM; Green MR; Chaudhuri J; Elemento O; Farinha P; Weng AP; Nissen MD; Steidl C; Morin RD; Scott DW; Privé GG; Melnick AM
Cell; 2020 Jul; 182(2):297-316.e27. PubMed ID: 32619424
[TBL] [Abstract][Full Text] [Related]
31. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
[TBL] [Abstract][Full Text] [Related]
32. Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in
Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
Oncotarget; 2018 Aug; 9(67):32882. PubMed ID: 30214692
[TBL] [Abstract][Full Text] [Related]
33. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Okosun J; Bödör C; Wang J; Araf S; Yang CY; Pan C; Boller S; Cittaro D; Bozek M; Iqbal S; Matthews J; Wrench D; Marzec J; Tawana K; Popov N; O'Riain C; O'Shea D; Carlotti E; Davies A; Lawrie CH; Matolcsy A; Calaminici M; Norton A; Byers RJ; Mein C; Stupka E; Lister TA; Lenz G; Montoto S; Gribben JG; Fan Y; Grosschedl R; Chelala C; Fitzgibbon J
Nat Genet; 2014 Feb; 46(2):176-181. PubMed ID: 24362818
[TBL] [Abstract][Full Text] [Related]
34. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome.
Nocturne G; Boudaoud S; Miceli-Richard C; Viengchareun S; Lazure T; Nititham J; Taylor KE; Ma A; Busato F; Melki J; Lessard CJ; Sivils KL; Dubost JJ; Hachulla E; Gottenberg JE; Lombès M; Tost J; Criswell LA; Mariette X
Blood; 2013 Dec; 122(25):4068-76. PubMed ID: 24159176
[TBL] [Abstract][Full Text] [Related]
35. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
Parry M; Rose-Zerilli MJ; Ljungström V; Gibson J; Wang J; Walewska R; Parker H; Parker A; Davis Z; Gardiner A; McIver-Brown N; Kalpadakis C; Xochelli A; Anagnostopoulos A; Fazi C; de Castro DG; Dearden C; Pratt G; Rosenquist R; Ashton-Key M; Forconi F; Collins A; Ghia P; Matutes E; Pangalis G; Stamatopoulos K; Oscier D; Strefford JC
Clin Cancer Res; 2015 Sep; 21(18):4174-4183. PubMed ID: 25779943
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
37. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
38. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
Hirsch B; Grünbaum M; Wagner F; Bi Y; Lucka L; Du MQ; Stein H; Dürkop H
Histopathology; 2012 May; 60(6B):E19-27. PubMed ID: 22393903
[TBL] [Abstract][Full Text] [Related]
39. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239
[TBL] [Abstract][Full Text] [Related]
40. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
